Floatz logo

Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pidnarulex
Invasive Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Castration-Resistant Prostate Carcinoma
Peter MacCallum Cancer Centre, AustraliaP1CC (43)
Pidnarulex
HER2 Positive Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Piflufolastat
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
Pimicotinib
Neoplasm
Abbisko Therapeutics Co, LtdP1CC (43)
Pimicotinib
Tenosynovial Giant Cell Tumor
Abbisko Therapeutics Co, LtdP1CC (43)
Pimitespib
Breast Cancer
Brown UniversityP1CC (43)
Pimitespib
Alveolar Soft Part Sarcoma
Taiho Pharmaceutical Co., Ltd.P1CC (43)
Pimitespib
Biliary Tract Cancer
Taiho Pharmaceutical Co., Ltd.P1CC (43)
Pimitespib
Urinary Bladder Carcinoma
Brown UniversityP1CC (43)
Pimitespib
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.P1CC (43)
Pimitespib
Endometrial Carcinoma
Brown UniversityP1CC (43)
Pimitespib
Esophageal Cancer
Taiho Pharmaceutical Co., Ltd.P1CC (43)
Pimitespib
Gastric Cancer
Taiho Pharmaceutical Co., Ltd.P1CC (43)
Pimitespib
Head And Neck Cancer
Taiho Pharmaceutical Co., Ltd.P1CC (43)
Pimitespib
Non-Small Cell Lung Carcinoma
Taiho Pharmaceutical Co., Ltd.P1CC (43)
Pimitespib
Pancreatic Ductal Adenocarcinoma
Taiho Pharmaceutical Co., Ltd.P1CC (43)
Pimitespib
Retinoblastoma
Brown UniversityP1CC (43)
Pimitespib
Small Cell Lung Carcinoma
Brown UniversityP1CC (43)
Pimitespib
Soft Tissue Sarcoma
Brown UniversityP1CC (43)
Pimitespib
Refractory Malignant Neoplasm
Brown UniversityP1CC (43)
Showing 3876 to 3900 of 9,920 assets
PreviousPage 156 of 397Next